pharma
Pharma & AI
pharma
Roswell Park Experts Bring AI and Precision Surgery to Head and Neck Cancer
pharma
AI Alone Can't Fix Prescription Translation, Report Says
pharma
Dash Bio Lands $30M Series A for a Pitch Investors Didn't Want to Hear
pharma
BioNTech Taps Sobi Chief Guido Oelkers as Its Next CEO
pharma
Supernus and Indivior Strike All-Stock Merger to Build a Brain-Drug Specialist
pharma
India's Traditional Medicine Ministry Steps Into Its AI Moment
pharma
AI Moves From the Scan Room to the Bedside
pharma
Insilico Medicine Wants to Grade the AI Models Trying to Invent Drugs
pharma
Can AI Actually Discover Drugs? Insilico Proposes a Scorecard
pharma
After 37 Years, Ionis' Founding Scientist Frank Bennett Is Stepping Away
pharma
Novo Nordisk's Heart Drug Flunks Phase 3, Denting a Whole Theory of Heart Disease
pharma
Dario Health Rolls Out an Integrated GLP-1 Management Platform
pharma
Seizure-Predicting Wearables Are Having a Moment, and Analysts See 22.3% Annual Growth
pharma
Bad News Week for Biotech: FDA Doubts, a 60% Stock Drop and a Sarepta Shakeup
pharma
AI Is Closing the Data Loop in Drug Discovery — and Speeding Up the Search
pharma
AI Moves Into Drug Safety Testing, Where Guessing Wrong Costs Lives
pharma
AstraZeneca's AI Has Yet to Produce a Single Drug Candidate — But Its CEO Sees Another Use
pharma
The AI Skeptic Ships an AI Agent: Schrödinger Launches Bunsen
pharma
OpenAI Is Linking 300 Million Weekly Health Questions to Real Medical Records
pharma
AI Is Moving Deeper Into Hospitals — And the Reporting Is Only Starting to Catch Up
pharma
AI Is Getting Better at Picking Which IVF Embryos Have the Best Shot
pharma
Biotech Meets AI: India's Bid for Global Scientific Leadership
pharma
Big Pharma Bets on AI to Speed Up the Hunt for New Drugs
pharma
Smarter Sonograms: Generative AI Steps Into the Ultrasound Room
pharma
AI Drug Discovery Draws Investor Buzz as Market Forecasts Reach Billions
pharma
Exon-Editing Founder Michael Ehlers Jumps to AI Biotech Formation Bio
pharma
Bristol Myers Squibb Buys Nvidia's Vera Rubin to Speed Up Drug Discovery
pharma
AI Promises One-Year Drug Discovery — But Data and Regulation Stand in the Way
pharma
Scientists Enlist AlphaFold AI to Make Gene Editing Safer
pharma
Tempus Buys Cancer Test Maker Personalis in $1.5B Deal
pharma
Bristol Myers Squibb Doubles Down on NVIDIA to Supercharge Drug Discovery
pharma
Bristol Myers Squibb Bets on Nvidia's Newest Supercomputer to Speed Up Drug Discovery
pharma
Latigo Pharmaceuticals Charts IPO to Fund Its Non-Opioid Pain Drugs
pharma
Pharma's Nvidia Rush: Certara and Bristol Myers Wire Up AI for Drug Development
pharma
UK Biotech Funding Roars Back to a Record in Q2 2026
pharma
United Imaging's AI Arm Rejects an "Extreme" Rollout, Co-CEO Says
pharma
Bristol Myers and Nvidia to Build Pharma's Most Powerful AI Supercomputer
pharma
An AI Agent Built to Help Doctors Manage a Common Heart Rhythm Disorder
pharma